America June 12, 2025
BioNTech to Acquire CureVac in $1.25B Deal
In a bold move that could redefine the future of mRNA-driven cancer therapies, German biotech giant BioNTech SE announced Thursday…
America June 12, 2025
In a bold move that could redefine the future of mRNA-driven cancer therapies, German biotech giant BioNTech SE announced Thursday…
By Rihem Akkouche
Business August 29, 2022
Moderna (NASDAQ: MRNA) filed a lawsuit against Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX), alleging that its competitors infringed its…
By Marivic Cabural Summers
Business August 26, 2021
Vaccines from Moderna, Pfizer, and BioNTech have come in a record time compared to other vaccines. However, the power of…
By Rochdi Rais
America December 23, 2020
The United States government inked a second agreement to purchase additional 100 million doses of the BioNTech-Pfizer COVID-19 vaccine, bringing…
By Dee Dulfo
Business November 22, 2020
The U.S. Food and Drug Administration (FDA) granted Regeneron Pharmaceuticals (NASDAQ; REGN) an emergency use authorization (EUA) for its COVID-19…
By Marivic Cabural Summers
America November 19, 2020
Pfizer (NYSE: PFE) is prepared to immediately distribute its COVID-19 vaccine after obtaining regulatory approval, according to its chief executive…
By Marivic Cabural Summers
Health November 9, 2020
Pfizer (NYSE: PFE) and BioNTech (Nasdaq: BNTX) are one step closer to developing a COVID-19 vaccine, which the companies tout has an effectiveness…
By Colby McCoy
U.S. News July 23, 2020
On Wednesday, Health and Human Services Secretary Alex Azar, announced U.S. government plans to pay $1.95 billion for 100 million…
By Colby McCoy